A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1).
Marijo BilusicNicole J ToneyRenee N DonahueSusan WroblewskiMatthew ZibelmanPooja GhataliaEric A RossFatima KarzaiRavi A MadanWilliam L DahutJames L GulleyJeffrey SchlomElizabeth R PlimackDaniel M GeynismanPublished in: Prostate cancer and prostatic diseases (2022)
Trial Registration Number: NCT02614859.
Keyphrases